Literature DB >> 10616362

Bacterial vaginosis is not associated with circumcision status of the current male partner.

J M Zenilman1, A Fresia, B Berger, W M McCormack.   

Abstract

OBJECTIVE: Bacterial vaginosis (BV) is common in sexually active women, and in a large proportion the underlying aetiology is unknown. We evaluated partner circumcision status as a potential risk and hypothesised that women with uncircumcised partners were at increased risk for BV.
METHODS: Retrospective audit of a partner study (272 heterosexual couples) conducted in Baltimore between 1990 and 1992. BV defined by clinical criteria and circumcision status of males was determined by physical examination.
RESULTS: BV was diagnosed in 83 (30%) female partners; 75 (27%) males were uncircumcised. In males and females respectively, gonorrhoea was diagnosed in 20% and 16%, and chlamydia in 7% and 11%. In women with circumcised partners, 58/197 (29%) had BV compared with 25/75 (33%) with uncircumcised partners (p = 0.53).
CONCLUSION: Women with uncircumcised current partners are not at increased risk for BV.

Entities:  

Mesh:

Year:  1999        PMID: 10616362      PMCID: PMC1758232          DOI: 10.1136/sti.75.5.347

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  11 in total

Review 1.  Vaginitis.

Authors:  J D Sobel
Journal:  N Engl J Med       Date:  1997-12-25       Impact factor: 91.245

2.  Reservoir of four organisms associated with bacterial vaginosis suggests lack of sexual transmission.

Authors:  E Holst
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

3.  Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections.

Authors:  S E Hawes; S L Hillier; J Benedetti; C E Stevens; L A Koutsky; P Wolner-Hanssen; K K Holmes
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

4.  Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group.

Authors:  R L Goldenberg; M A Klebanoff; R Nugent; M A Krohn; S Hillier; W W Andrews
Journal:  Am J Obstet Gynecol       Date:  1996-05       Impact factor: 8.661

5.  Comparative periurethral bacteriology of uncircumcised and circumcised males.

Authors:  F Serour; Z Samra; Z Kushel; A Gorenstein; M Dan
Journal:  Genitourin Med       Date:  1997-08

6.  HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis.

Authors:  N Sewankambo; R H Gray; M J Wawer; L Paxton; D McNaim; F Wabwire-Mangen; D Serwadda; C Li; N Kiwanuka; S L Hillier; L Rabe; C A Gaydos; T C Quinn; J Konde-Lule
Journal:  Lancet       Date:  1997-08-23       Impact factor: 79.321

7.  Hospital-based study of sexually transmitted diseases at Murewa rural district hospital, Zimbabwe 1991-1992.

Authors:  S A Tswana; L Nyström; S R Moyo; J Blomberg; J Tianani; M Nzara; L Chieza
Journal:  Sex Transm Dis       Date:  1995 Jan-Feb       Impact factor: 2.830

8.  Alcohol and other substance use in STD clinic patients: relationships with STDs and prevalent HIV infection.

Authors:  J M Zenilman; E W Hook; M Shepherd; P Smith; A M Rompalo; D D Celentano
Journal:  Sex Transm Dis       Date:  1994 Jul-Aug       Impact factor: 2.830

9.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

10.  Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study.

Authors:  D Avonts; M Sercu; P Heyerick; I Vandermeeren; A Meheus; P Piot
Journal:  Sex Transm Dis       Date:  1990 Jan-Mar       Impact factor: 2.830

View more
  8 in total

1.  Paternal race and bacterial vaginosis during the first trimester of pregnancy.

Authors:  Hyagriv N Simhan; Lisa M Bodnar; Marijane A Krohn
Journal:  Am J Obstet Gynecol       Date:  2008-02       Impact factor: 8.661

2.  Topical penile microbicide use by men to prevent recurrent bacterial vaginosis in sex partners: a randomized clinical trial.

Authors:  Elizabeth Bukusi; Katherine K Thomas; Rosemary Nguti; Craig R Cohen; Noel Weiss; Robert W Coombs; King K Holmes
Journal:  Sex Transm Dis       Date:  2011-06       Impact factor: 2.830

3.  The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda.

Authors:  Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Fred Nalugoda; Stephen Watya; Laurence Moulton; Michael Z Chen; Nelson K Sewankambo; Noah Kiwanuka; Victor Sempijja; Tom Lutalo; Joseph Kagayii; Fred Wabwire-Mangen; Renée Ridzon; Melanie Bacon; Maria J Wawer
Journal:  Am J Obstet Gynecol       Date:  2008-10-30       Impact factor: 8.661

4.  Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision.

Authors:  Aaron A R Tobian; Ronald H Gray; Thomas C Quinn
Journal:  Arch Pediatr Adolesc Med       Date:  2010-01

5.  The epidemiology of bacterial vaginosis in relation to sexual behaviour.

Authors:  Hans Verstraelen; Rita Verhelst; Mario Vaneechoutte; Marleen Temmerman
Journal:  BMC Infect Dis       Date:  2010-03-30       Impact factor: 3.090

Review 6.  Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis.

Authors:  Lenka A Vodstrcil; Jane S Hocking; Matthew Law; Sandra Walker; Sepehr N Tabrizi; Christopher K Fairley; Catriona S Bradshaw
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

Review 7.  Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?

Authors: 
Journal:  PLoS Med       Date:  2009-09-08       Impact factor: 11.069

Review 8.  Association between male circumcision and women's biomedical health outcomes: a systematic review.

Authors:  Jonathan M Grund; Tyler S Bryant; Inimfon Jackson; Kelly Curran; Naomi Bock; Carlos Toledo; Joanna Taliano; Sheng Zhou; Jorge Martin Del Campo; Ling Yang; Apollo Kivumbi; Peizi Li; Sherri Pals; Stephanie M Davis
Journal:  Lancet Glob Health       Date:  2017-11       Impact factor: 26.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.